Merion Station, PA, United States of America

Katherine A High

This inventor holds 29 USPTO granted patents and 20 published patent applications, plus 12 CIPO patents and 12 EPO patents. Top assignees: The Children's Hospital of Philadelphia, Sangamo Biosciences, Inc., The University of North Carolina at Chapel Hill. Active years: 2000-2026.

USPTO Granted Patents = 29 (Patent Applications = 20)

% Patents Active = 96.6

CIPO Patents = 12 (Patent Applications = 5)

EPO Patents = 12 (Patent Applications = 19)

Average Co-Inventor Count = 3.1

ph-index = 9

Forward Citations = 229(Granted Patents)

Location History:

Philadelphia, PA (US) (2015 - 2017)
Merion, PA (US) (2000 - 2023)
Merion Station, PA (US) (2016 - 2024)

Company Filing History:

29 out of 299

The Children's Hospital of Philadelphia

patents

3 out of 160

Sangamo Biosciences, Inc.

patents

1 out of 1,324

The University of North Carolina at Chapel Hill

patents

4. 1 out of 2,645

University of Pennsylvania

patents

where one patent can have more than one assignee

Years Active: 2000-2026

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527848 - Protein C Zymogen and Methods of Use Thereof to Prevent Cancer Metastases (2026-01-20),

2. 11939590 - AAV vector compositions and methods for gene transfer to cells, organs and tissues (2024-03-26),

3. 11896652 - Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues (2024-02-13),

4. 11878056 - Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy (2024-01-23),

5. 11807865 - Large commercial scale lentiviral vector production system and vectors produced thereby (2023-11-07),

6. 11559589 - Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy (2023-01-24),

7. 11491213 - Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues (2022-11-08),

8. 11408899 - AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies (2022-08-09),

9. 11279950 - Composition and methods for highly efficient gene transfer using AAV capsid variants (2022-03-22),

10. 11110153 - Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues (2021-09-07),

11. 11014975 - Expression cassette for packaging and expression of variant factor VIII for the treatment of hemostasis disorders (2021-05-25),

12. 10799566 - Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissues (2020-10-13),

13. 10640785 - Virus vectors for highly efficient transgene delivery (2020-05-05),

14. 10448823 - Apparatus and methods for testing visual function and functional vision at varying luminance levels (2019-10-22),

15. 10392632 - AAV8 vector with enhanced functional activity and methods of use thereof (2019-08-27),

Title: The Innovative Journey of Katherine A. High

Introduction: Katherine A. High, a pioneering inventor based in Merion Station, PA (US), has made significant contributions to the field of biotechnology and genetics.

Latest Patents: Katherine A. High holds several patents related to gene therapy and genetic engineering, focusing on innovative solutions for various medical conditions.

Career Highlights: With a distinguished career spanning decades, Katherine A. High has held key positions in renowned research institutions and biotech companies, leading groundbreaking projects in the development of novel therapies.

Collaborations: Throughout her career, Katherine A. High has collaborated with top scientists, researchers, and medical professionals to advance the field of gene therapy, fostering a culture of innovation and excellence.

Conclusion: Katherine A. High's relentless pursuit of innovation and her groundbreaking work in gene therapy have significantly impacted the medical and biotechnological landscapes, solidifying her legacy as a trailblazing inventor in the field.